PTSM: Pharmaceutical Technology Sourcing and Management
Patheon will add spray drying, sterile manufacturing, and packaging capabilities to four facilities.
Patheon announced plans to invest $45 million in spray drying, sterile manufacturing, and packaging and serialization equipment and facilities at four sites in the company’s global network, according to a June 29, 2017 press statement.
The expansions include a 15,000-sq.-ft. suite at the company’s Florence, SC facility that will contain two spray dryers for development and commercial scale spray-dried dispersion (SDD) services. The suite is scheduled to be online in 2019.
The company also announced plans to expand existing development SDD capabilities at the Bend, OR site with a new cGMP analytical lab, manufacturing suite, and additional development-scale spray drying.
At the Monza, Italy site, Patheon plans to invest in in a commercial sterile product manufacturing facility that will house three, 40-sq.-m lyophilizers with integrated filling equipment for lyo and liquid formulations for small and large molecules in a range of vial specifications. The equipment will feature clean-in-place systems and auto loading for the lyophilizers contained in restricted access barrier systems. Other planned additions include a sterile product development suite with two lyophilizers, sterile vial filling line, and analytical laboratory. The facility is scheduled to be operational in mid-2019.
The company also announced expansion of the packaging and serialization capabilities at its Greenville, NC site including a new filling and packaging suite and an upgraded packaging line. The new 4,800-sq.-ft. suite, scheduled tocome online in the fall of 2017, will feature a filling and packaging line, and an Optel serialization system with cameras, pharma proof stations, line master, and bottle and bundle tracker equipment.
Source: Patheon
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.